Technological watch

COVID-19 Impact and Recovery Analysis - Global Synthetic Biology Market 2020-2024

LONDON--(BUSINESS WIRE)--The global synthetic biology market is expected to grow by USD 11.52 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Healthy growth is expected to continue throughout the forecast period.



Request for Technavio's latest reports on directly and indirectly impacted markets

Market estimates include pre- and post-COVID-19 impact on the synthetic biology market - View market snapshot before purchasing

Major Five Synthetic Biology Companies:

Amyris Inc.

Amyris Inc. operates its business through the unified segment. The company provides synthetic biology solutions to different end-users. The company engineers organisms through its proprietary process of synthetic biology.

Algenol

Algenol operates its business through segments such as Sustainable products and Customized services. The company is specialized in converting algae into high purity commercial products, such as spirulina and spirulina protein isolates, algae extracts used in the personal care products, and green crude or bio-fuels.

DuPont de Nemours Inc.

DuPont de Nemours Inc. operates its business through segments such as Electronics and Imaging, Nutrition and Biosciences, Transportation and Industrial, and Safety and Construction. The company provides synthetic biology products and services to various industries, such as food and beverages, fabric and home care, and personal care.

Genomatica Inc.

Genomatica Inc. operates its business through segments such as Products and Services. The company provides synthetic biology solutions to different end-users such as nutraceuticals, probiotics, enzymes, flavors, cosmetics, etc. manufacturers. The company is specialized in bio-engineering and has a system-level approach to designing a microorganism and production process at the same time.

Integrated DNA Technologies Inc.

Integrated DNA Technologies Inc. operates its business through the Synthetic biology products and services segment. The company is specialized in several synthetic biology products that have genomic applications. Some of these products include DNA & RNA, CRISPR genome editing, next-generation sequencing products, genes & gene fragments, qPCR & PCR primers, GMP, OEM & integrations, and IDT Oligo card.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Healthcare
Include:

Publication date: 01/07/2020

Business Wire

      

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.